Scientists use AI to develop drugs that can treat opioid addiction

México Noticias Noticias

Scientists use AI to develop drugs that can treat opioid addiction
México Últimas Noticias,México Titulares
  • 📰 IntEngineering
  • ⏱ Reading Time:
  • 88 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 63%

Researchers at the Icahn School of Medicine at Mount Sinai hope to alleviate opioid addiction by using AI to discover drugs that inhibit the kappa-opioid receptor. Find out more at 🚀 engineering interestingengineering

, and every year, more than 80,000 Americans die from overdoses related to the condition?

Opioid drugs function by activating opioid receptors that lead to pain alleviation and well-being. Unfortunately, they also trigger physical dependence and decreased breathing, the latter often unfortunately leading to death during a drug overdose.Past preclinical studies conducted have found that blocking these kappa-opioid receptors may offer help in treating opioid dependence, according to multiple media reports published on Saturday.

“If you’re addicted, and you’re trying to quit, at some point, you will get withdrawal symptoms, and those can be really hard to overcome,” Estrada explained to“After a lot of opioid exposure, your brain gets rewired to need more drugs. Blocking the activity of the kappa opioid receptor has been shown in animal models to reduce this need to use drugs in the withdrawal period.”

The challenge of this task is in uncovering the drugs that can actually block the activity of a protein, such as the kappa-opioid receptor, in a sea of countless candidates. That’s why Estrada turned to computational tools to make the process more efficient. Estrada is using artificial intelligence to optimize her drug-finding systems.“Artificial intelligence has the advantage of being able to take huge amounts of information and learn to recognize patterns from it.

Estrada’s team trained a computer model to generate compounds that might block the receptor with a reinforcement learning algorithm that rewarded properties that are favorable for drug treatments. They did this by combining information about the kappa-opioid receptor and known drugs.that have promising attributes. They are now aiming to synthesize them and eventually test them in animal models for safety and effectiveness.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

IntEngineering /  🏆 287. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

14-year-old killed after stabbing near school in East Side High School in Paterson14-year-old killed after stabbing near school in East Side High School in PatersonThe attack took place on Park Avenue near East Side High School at the end of the school day around 3 p.m.
Leer más »

Police find 2,000 dead cats intended for use in traditional medicine in VietnamPolice find 2,000 dead cats intended for use in traditional medicine in VietnamVietnamese police have discovered around 2,000 dead cats intended for use in traditional medicine, state media said Friday.
Leer más »

CRISPR gene-editing therapies for hypertrophic cardiomyopathy - Nature MedicineCRISPR gene-editing therapies for hypertrophic cardiomyopathy - Nature MedicinePre-symptomatic gene editing for hypertrophic cardiomyopathy: In our latest News & Views, Alanna Strong discusses new preclinical data and concludes that, despite the challenges, it is a strategy worth pursuing in the clinic. ChildrensPhila PennMedicine
Leer más »

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice - Nature MedicineEfficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice - Nature MedicineTwo approaches using an adenine base editor and a Cas9 nuclease prevented the development of hypertrophic cardiomyopathy in mice carrying a pathogenic mutation on the Myh6 gene, highlighting the potential of single-dose genetic therapies for the treatment of cardiac disease.
Leer más »

Celery Seed-Derived Medicine May Improve Stroke OutcomesCelery Seed-Derived Medicine May Improve Stroke OutcomesButylphthalide, a new medication that comes from celery seed, could improve outcomes after a clot-caused stroke when given in addition to prompt treatment for the clot, according to a new study.
Leer más »

Genomic medicine offers diagnostic hope for people with rare diseases | Pediatric ResearchGenomic medicine offers diagnostic hope for people with rare diseases | Pediatric ResearchAn 18-year-old experienced symptoms of her rare disease from birth, but it wasn’t until 2020 that she got her diagnosis thanks to genomic medicine.
Leer más »



Render Time: 2025-02-27 22:00:37